Our study supports the idea that genetic variations in C4, CR1, and CR3, associated with autoimmune disease susceptibility (68–70), could disrupt PGN recognition and promote systemic inflammatory conditions (3). This evidence concerns the gene CRIPTO3 and autoimmune disease.